Biogen Idec sells BENLYSTA royalty rights to DRI Capital managed fund
Biogen Idec has sold to a DRI Capital managed fund…
10 September 2012 | By Biogen Idec
Biogen Idec has sold to a DRI Capital managed fund its royalty and other rights relating to BENLYSTA®...